NanoViricides: Fiscal Q3 Earnings Snapshot - The Washington Post
3 days ago • Google News
NanoViricides Inc (NNVC)
US$ 1.44-3.36%
Price Chart
Key Statistics
Market Cap
$ 22.05M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
114.1K
52W High
$ 3.59
52W Low
$ 0.94
Dividend Yield
0.00%
Beta
0.95
Technicals
50-Day MA
1.2548
200-Day MA
1.435
52 Week High
3.59
52 Week Low
0.94
About NNVC
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections.
Employees
7
Headquarters
Shelton, CT
CEO
Dr. Anil R. Diwan Ph.D.
Latest News
NanoViricides: Fiscal Q3 Earnings Snapshot - Huron Daily Tribune
2 days ago • Google News
NanoViricides: Fiscal Q3 Earnings Snapshot - San Francisco Chronicle
3 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg